Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
The uncertainty right now is brutal. From what I’m hearing around the office, it seems like they are focusing heavily on those legacy product lines to pivot resources toward newer AI-related workflows. If you are in R&D support, I’d suggest bracing for the worst. The lack of clear communication is standard procedure here, which unfortunately tells you everything you need to know about the company's priorities. Hope you manage to get some clarity soon, but keep your resume polished just in case this really is just the first wave.
I wouldn't hold my breath waiting for management to clarify if this is global or just local to the DC filing. Usually, these headcount adjustments start with the low-hanging fruit in the main offices before they quietly trickle down to the international satellite teams. The way they handle these 'notifications' always feels cold and detached. If your role isn't directly tied to the primary growth initiatives, you should probably assume you're at risk. It’s a tough spot to be in, but looking at the broader market trends, it feels like they are trimming fat across the board.